In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sparq's Vitamin Vapor Inhalation Product Could Spark Regulatory Interest

This article is powered by The Rose Sheet

Executive Summary

Vitamin Air is so novel, it could get FDA's attention for misbranding as a supplement and being an unapproved new drug. Sparq says it's not an electronic cigarette because there's no nicotine in formulations it offers in products that resemble early-edition e-cigarettes. But it is a dietary supplement because each one is a mixture of vitamins, minerals and supplements plus natural flavors and glycerin so the formulations heat into vapor that is inhaled, the firm says.

You may also be interested in...



Vitamin Vapor Ad Claims Review Douses FDA's Dietary Supplement Definition

The first review of ad claims for a vitamin vapor device by a Council of Better Business Bureaus investigative unit comes as marketing of the products is proliferating and with FDA stating that "a vitamin product for inhalation cannot be legally marketed as a dietary supplement" in the US.

FDA Helps E-Cigarettes Navigate NDA Process With Nonclinical Tests Guidance

Commissioner Gottlieb highlights the first of two draft guidances US FDA will publish on developing "novel, inhaled nicotine replacement therapies that could be submitted to the FDA for approval as new drugs, similar to current" OTC  nicotine replacement therapies. FDA has had a contentious history with manufacturers of electronic nicotine devices, but officials have said the products are eligible for review as NRTs through the NDA process.

FDA Warns Supplement Own-Labeler, Hawaii Noni Leather And Lotion Provider

California herbal remedy and acupuncture provider is latest own-label supplement marketer FDA warns about violations of its GMP, claims and labeling regulations. Hawaii organic noni nutritional and topical product firm receives warnings listing its claims and branding violations.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS122381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel